The Nurse's Role in Managing Chemotherapy-Induced Nausea and Vomiting An International Survey

被引:19
|
作者
Krishnasamy, Meinir [1 ,2 ]
So, Winnie Kwok-Wei [3 ]
Yates, Patsy [4 ]
Esperanza Ayala de Calvo, Luz [5 ]
Annab, Rachid [1 ,2 ]
Wisniewski, Tami [6 ]
Aranda, Sanchia [1 ,2 ,7 ]
机构
[1] Peter MacCallum Canc Ctr, East Melbourne, Vic 8006, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia
[3] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Hong Kong, Peoples R China
[4] Queensland Univ Technol, Sch Nursing & Midwifery, Brisbane, Qld 4001, Australia
[5] Pontificia Univ Javeriana, Sch Nursing, Bogota, Colombia
[6] Merck & Co Inc, Whitehouse Stn, NJ USA
[7] Canc Inst New South Wales, Sydney, NSW, Australia
关键词
Cancer; Chemotherapy-induced nausea and vomiting; Education; Nurses;
D O I
10.1097/NCC.0b013e3182a3534a
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Nurses play a substantial role in the prevention and management of chemotherapy-induced nausea and vomiting (CINV). Objectives: This study set out to describe nurses' roles in the prevention and management of CINV and to identify any gaps that exist across countries. Methods: A self-reported survey was completed by 458 registered nurses who administered chemotherapy to cancer patients in Australia, China, Hong Kong, and 9 Latin American countries. Results: More than one-third of participants regarded their own knowledge of CINV as fair to poor. Most participants (965%) agreed that chemotherapy-induced nausea and chemotherapy-induced vomiting should be considered separately (79%), but only 35% were confident in their ability to manage chemotherapy-induced nausea (53%) or chemotherapy-induced vomiting (59%). Only one-fifth reported frequent use of a standardized CINV assessment tool and only a quarter used international clinical guidelines to manage CINV. Conclusions: Participants perceived their own knowledge of CINV management to be insufficient. They recognized the need to develop and use a standardized CINV assessment tool and the importance of adopting international guidelines to inform the management of CINV. Implications for Practice: Findings indicate that international guidelines should be made available to nurses in clinically relevant and easily accessible formats, that a review of chemotherapy assessment tools should be undertaken to identify reliable and valid measures amenable to use in a clinical settings, and that a CINV risk screening tool should be developed as a prompt for nurses to enable timely identification of and intervention for patients at high risk of CINV.
引用
收藏
页码:E27 / E35
页数:9
相关论文
共 50 条
  • [41] Dietary strategies for chemotherapy-induced nausea and vomiting: A systematic review
    Gala, Devanshi
    Wright, Hattie H.
    Zigori, Bekhinkosi
    Marshall, Skye
    Crichton, Megan
    CLINICAL NUTRITION, 2022, 41 (10) : 2147 - 2155
  • [42] Rolapitant (Varubi) for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1487): : 17 - 18
  • [43] New options and controversies in the management of chemotherapy-induced nausea and vomiting
    Koth, Sara M.
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (11) : 812 - 819
  • [44] Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting
    Celio, Luigi
    Denaro, Angela
    Canova, Stefania
    Gevorgyan, Arpine
    Bajetta, Emilio
    TUMORI JOURNAL, 2008, 94 (04): : 447 - 452
  • [45] Granisetron Transdermal System in the Management of Chemotherapy-Induced Nausea and Vomiting
    Kitayama, Hiromitsu
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2016, 8 : 37 - 44
  • [46] ROLAPITANT HYDROCHLORIDE: PROPHYLACTIC TREATMENT FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    Navari, R.
    DRUGS OF TODAY, 2016, 52 (08) : 431 - 438
  • [47] Genetic Influence on Chemotherapy-Induced Nausea and Vomiting: A Narrative Review
    Kiernan, Jason
    ONCOLOGY NURSING FORUM, 2016, 43 (03) : 389 - 393
  • [48] How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study
    Vanbockstael, Julie
    Coquan, Elodie
    Gouerant, Sophie
    Allouache, Djelila
    Faveyrial, Audrey
    Noal, Sabine
    Delcambre, Corinne
    Galais, Marie-Pierre
    Heron, Jean-Francois
    Lefebvre, Anne-Charlotte
    Sevin, Emmanuel
    Hrab, Ioana
    Polycarpe, Florence
    Andre, Michel
    Kaluzinski, Laure
    Gervais, Radj
    Gunzer, Katharina
    Vie, Brigitte
    Saucier, Gilles
    Lemenand, Noemie
    Grellard, Jean-Michel
    Clarisse, Benedicte
    Dugue, Audrey Emmanuelle
    Joly, Florence
    SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1131 - 1138
  • [49] Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity
    Vig, Sierra
    Seibert, Laurel
    Green, Myke R.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (01) : 77 - 82
  • [50] Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity
    Sierra Vig
    Laurel Seibert
    Myke R. Green
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 77 - 82